We showed previously that blocking LPA1 activity inhibits early stage of breast cancer cell metastasis to lungs and bone, independently of cell proliferation and angiogenesis but through inhibition of cell motility and invasion [9]. Here, LPAR1 is linked to breast carcinoma.